Vor Biopharma Inc. Quarterly Return On Assets in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Vor Biopharma Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q2 2024.
  • Vor Biopharma Inc. Return On Assets for the quarter ending June 30, 2024 was -64.7 %, a 57.7% decline year-over-year.
  • Vor Biopharma Inc. annual Return On Assets for 2023 was -49.6 %, a 30% decline from 2022.
  • Vor Biopharma Inc. annual Return On Assets for 2022 was -38.2 %, a 48.2% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -64.7 -23.7 -57.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -57.3 -18.5 -47.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -49.6 -11.5 -30% Oct 1, 2023 Dec 31, 2023
Q3 2023 -44 -5.88 -15.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -41 -7.21 -21.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -38.8 -7.97 -25.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -38.2 -12.4 -48.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -38.1 -8.7 -29.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -33.8 Apr 1, 2022 Jun 30, 2022
Q1 2022 -30.8 Jan 1, 2022 Mar 31, 2022
Q4 2021 -25.8 Oct 1, 2021 Dec 31, 2021
Q3 2021 -29.4 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.